市场调查报告书
商品编码
1497602
心臟监测与心律管理市场:按产品、最终用户划分 - 全球预测 2024-2030 年Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), End-User (Ambulatory Center, Home Healthcare, Hospitals) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年心臟监测和心律管理市场规模为198亿美元,预计2024年将达207.4亿美元,2030年将达277.1亿美元,复合年增长率为4.91%。
心臟监测和心律管理是医疗保健的重要领域,涉及评估和管理心电活动和心律。这些技术对于诊断和治疗心律不整、心臟病和其他心血管疾病等心臟病患者至关重要。心血管疾病的增加,特别是在人口老化中,正在扩大对心臟监测和心律管理解决方案的需求。改善和扩大医疗基础设施,特别是在新兴国家,使更多人能够获得心臟护理技术并扩大市场。心臟监测和节律管理设备的高成本以及心臟监测和节律管理设备的技术挑战阻碍了市场的成长。无线和远端监控技术等技术创新的进步预计将使患者无需住院即可接受持续护理,从而创造市场成长机会。这些进步使医疗保健提供者可以更轻鬆地即时监测患者并调整治疗。
主要市场统计 | |
---|---|
基准年[2023] | 198亿美元 |
预测年份 [2024] | 207.4亿美元 |
预测年份 [2030] | 277.1亿美元 |
复合年增长率(%) | 4.91% |
区域洞察
由于先进的医疗基础设施、心血管疾病的高盛行率以及领先的医疗设备公司的存在,美洲地区的心臟监测和心律管理市场保持显着增长。此外,美国、巴西、墨西哥和加拿大对医疗保健进步和高支出的关注,以及无线和远端监控等技术的采用,也促进了该地区的强劲成长。由于人口老化加剧、文明病盛行率增加以及医疗保健支出增加等因素,亚太地区心臟监测和心律管理市场正在快速成长。由于医疗基础设施的改善、可支配收入的增加以及政府对医疗保健现代化的努力,中国、日本和印度等国家正在经历显着的成长。欧洲是欧洲、中东和非洲地区市场的主要贡献者,因为它透过强大的医疗保健系统、高昂的医疗保健成本和严格的法规确保高品质的医疗保健标准。受经济差异和医疗设施使用水准不同的影响,中东和非洲预计将成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在心臟监测和心律管理市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对心臟监测和心律管理市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在心臟监测和节律管理市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[196 Pages Report] The Cardiac Monitoring & Cardiac Rhythm Management Market size was estimated at USD 19.80 billion in 2023 and expected to reach USD 20.74 billion in 2024, at a CAGR 4.91% to reach USD 27.71 billion by 2030.
Cardiac monitoring & cardiac rhythm management are essential areas of healthcare that focus on evaluating and managing the heart's electrical activities and rhythms. These techniques are crucial for diagnosing and treating patients with heart conditions such as arrhythmias, heart attacks, and other cardiovascular issues. The increase in cardiovascular diseases, especially among aging populations, is expanding the need for cardiac monitoring & cardiac rhythm management solutions. Rising improvements and expansions in healthcare infrastructure, especially in emerging countries, enable more people to access cardiac care technologies, thus broadening the market. The high cost of cardiac monitoring & rhythm management devices and availability of technical challenges with cardiac monitoring & cardiac rhythm management devices hampers the market growth. Rising innovations such as wireless and remote monitoring technologies allow patients to receive continuous care without staying in a hospital are expected ro create opportunities for market growth. These advancements make it easier for healthcare providers to monitor patients and adjust treatments in real-time.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.80 billion |
Estimated Year [2024] | USD 20.74 billion |
Forecast Year [2030] | USD 27.71 billion |
CAGR (%) | 4.91% |
Regional Insights
The Americas region holds a substantial growth in the cardiac monitoring & cardiac rhythm management market due to presence of advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and the presence of leading medical device companies. Moreover, the adoption of technologies such as wireless and remote monitoring, along with a focus on healthcare advancements and significant healthcare spending in the U.S., Brazil, Mexico, and Canada, contributes to the robust growth in this region. The APAC region is marked by a rapid growth rate in the cardiac monitoring & cardiac rhythm management market, driven by factors such as the increasing aging population, growing prevalence of lifestyle diseases, and rising healthcare expenditure. Countries such as China, Japan, and India are experiencing significant growth due to improvements in healthcare infrastructure, rising disposable incomes, and governmental initiatives aimed at modernizing healthcare. Europe is a major contributor to the EMEA region's market because of its strong healthcare systems, high healthcare spending, and stringent regulations ensuring high-quality standards. The Middle East and Africa are expected to experience growth influenced by economic disparities and varying levels of access to healthcare facilities.
Market Insights
The market dynamics represent an ever-changing landscape of the Cardiac Monitoring & Cardiac Rhythm Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Abbott's Assert-IQ Cardiac Monitor Receives CE Mark Approval for Enhanced Heart Rhythm Management
Abbott received CE mark approval in Europe for Assert-IQ, an advanced insertable cardiac monitor capable of remotely tracking heart rhythms for up to six years. Equipped with Bluetooth technology, the device facilitates the detection and recording of irregular heartbeats, such as elusive atrial fibrillation episodes, and provides critical data alerts to clinicians to support optimal treatment decisions. [Published On: 2024-03-26]
FDA Approves Medtronic's Innovative Aurora EV-ICD System
Medtronic plc has secured FDA approval for its groundbreaking Aurora EV-ICD MRI SureScan system and associated Epsila EV MRI SureScan defibrillation lead. This advanced technology marks a significant innovation by incorporating the life-saving functionalities of conventional implantable cardioverter-defibrillators while strategically positioning the lead under the breastbone, external to the heart and veins. This arrangement allows the Aurora EV-ICD to deliver vital defibrillation, anti-tachycardia pacing, and preventative backup pacing, maintaining traditional devices' familiar size and durability. [Published On: 2023-09-23]
Advancements in Cardiac Monitoring: The Introduction of Boston Scientific's LUX-Dx II+ ICM System
Boston Scientific introduced the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, an advanced solution for continuous arrhythmia monitoring in patients with conditions such as atrial fibrillation, cryptogenic stroke, and syncope. This innovative device features a dual-stage algorithm that initially detects and subsequently verifies arrhythmias, ensuring only clinically relevant data prompts alerts to healthcare providers. The system's remote programming capabilities enhance patient comfort by adjusting event detection settings and symptom recording without the need for face-to-face visits, streamlining the management process and supporting timely, informed clinical decisions. [Published On: 2023-09-03]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiac Monitoring & Cardiac Rhythm Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cardiac Monitoring & Cardiac Rhythm Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics by Applied Cardiac Systems Inc., Alivecor, Inc., Asahi Kasei Corporation, Baxter International Inc., Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Spandan, Tricog Health, and Zoll Medical Corporation.
Market Segmentation & Coverage
Manual External Defibrillator
Wearable Cardioverter Defibrillator
T-ICD